{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Missouri%20Analytical%20Laboratories%20Inc","name":"Missouri Analytical Laboratories Inc","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-04T03:35:23.451Z"},"count":1,"matches":[{"id":"b245a8c470dde2d0","posted_date":"2021-10-12","letter_issue_date":"2021-09-30","company_name":"Missouri Analytical Laboratories Inc","issuing_office":"Division of Pharmaceutical Quality Operations III","subject":"CGMP/Active Pharmaceutical Ingredient (API)/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/b245a8c470dde2d0"}]}